TCG Crossover Management, LLC Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$1.0T
Holdings
38
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (38 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | CGONCG ONCOLOGY INC | 3,670,206 | $105.3B | 10.29% | |
| 2 | DYNDYNE THERAPEUTICS INC | 2,650,150 | $62.4B | 6.10% | |
| 3 | XNCRXENCOR INC | 2,452,138 | $56.4B | 5.51% | |
| 4 | COGTCOGENT BIOSCIENCES INC | 6,964,375 | $54.3B | 5.31% | |
| 5 | CNTACENTESSA PHARMACEUTICALS PLC | 2,890,816 | $48.4B | 4.73% | |
| 6 | OCULOCULAR THERAPEUTIX INC | 5,319,148 | $45.4B | 4.44% | |
| 7 | UPBUPSTREAM BIO INC | 2,801,763 | $44.9B | 4.38% | |
| 8 | ABVXABIVAX SA AMERICAN DEPOSITARY SHARES | 6,056,596 | $44.3B | 4.33% | |
| 9 | YB4PSAVARA INC | 12,362,205 | $38.0B | 3.71% | |
| 10 | TNGXTANGO THERAPEUTICS INC | 10,736,000 | $33.2B | 3.24% | |
| 11 | DNTHDIANTHUS THERAPEUTICS INC | 1,501,624 | $32.7B | 3.20% | |
| 12 | IRONDISC MEDICINE INC | 486,957 | $30.9B | 3.02% | |
| 13 | MLYSMINERALYS THERAPEUTICS INC | 2,470,265 | $30.4B | 2.97% | |
| 14 | TRMLTOURMALINE BIO INC | 1,477,593 | $30.0B | 2.93% | |
| 15 | GPCRSTRUCTURE THERAPEUTICS INC | 1,063,000 | $28.8B | 2.82% | |
| 16 | TYRATYRA BIOSCIENCES INC | 1,989,103 | $27.6B | 2.70% | |
| 17 | EYPTEYEPOINT PHARMACEUTICALS INC | 3,572,335 | $26.6B | 2.60% | |
| 18 | CDTXCidara Therapeutics, Inc. | 1,005,901 | $26.1B | 2.55% | |
| 19 | THRDTHIRD HARMONIC BIO INC | 2,505,424 | $25.8B | 2.52% | |
| 20 | SLNOSOLENO THERAPEUTICS INC | 550,000 | $24.7B | 2.42% | |
| 21 | CATBUSDASTRIA THERAPEUTICS INC | 2,761,861 | $24.7B | 2.41% | |
| 22 | FULCFULCRUM THERAPEUTICS INC | 5,250,000 | $24.7B | 2.41% | |
| 23 | SLNSILENCE THERAPEUTICS PLC | 3,033,560 | $20.9B | 2.04% | |
| 24 | RAPTEURRAPT Therapeutics, Inc. | 13,135,260 | $19.8B | 1.93% | |
| 25 | AMLXAMYLYX PHARMACEUTICALS INC | 4,643,812 | $17.6B | 1.72% | |
| 26 | CMPSCOMPASS PATHWAYS LTD | 3,858,000 | $14.6B | 1.43% | |
| 27 | KURAKURA ONCOLOGY INC | 1,423,642 | $12.4B | 1.21% | |
| 28 | MBXMBX BIOSCIENCES INC | 650,000 | $12.0B | 1.17% | |
| 29 | KODKODIAK SCIENCES INC | 1,145,538 | $11.4B | 1.11% | |
| 30 | TRDAENTRADA THERAPEUTICS INC | 584,955 | $10.1B | 0.99% | |
| 31 | KROSKEROS THERAPEUTICS INC | 550,000 | $8.7B | 0.85% | |
| 32 | AVU0ADVERUM BIOTECHNOLOGIES INC | 1,796,482 | $8.4B | 0.82% | |
| 33 | VTGNVISTAGEN THERAPEUTICS INC | 2,676,580 | $7.9B | 0.77% | |
| 34 | AVTEAEROVATE THERAPEUTICS INC | 2,240,809 | $5.9B | 0.58% | |
| 35 | NKTREURNEKTAR THERAPEUTICS | 4,000,000 | $3.7B | 0.36% | |
| 36 | AVTXAVALO THERAPEUTICS INC | 483,000 | $3.6B | 0.35% | |
| 37 | VTYXVENTYX BIOSCIENCES INC | 316,195 | $692.5M | 0.07% | |
| 38 | CABACABALETTA BIO INC | 86,795 | $197.0M | 0.02% |